Therapeutic advances demand accurate typing of amyloid deposits Ernesto Anesi, MD, Giovanni Palladini, MD, Vittorio Perfetti, MD, Eloisa Arbustini, MD, Laura Obici, MD, Giampaolo Merlini, MD  The American Journal of Medicine  Volume 111, Issue 3, Pages 243-244 (August 2001) DOI: 10.1016/S0002-9343(01)00774-4

Figure Electron micrograph showing 10-nm immunogold labeling with anti-transthyretin antibody of abdominal fat amyloid fibrils. Bar scale = 0.6 μm (magnification ×12 000). The American Journal of Medicine 2001 111, 243-244DOI: (10.1016/S0002-9343(01)00774-4)